Fisher & Paykel Healthcare Future Growth
Future criteria checks 4/6
Fisher & Paykel Healthcare is forecast to grow earnings and revenue by 17.9% and 10.3% per annum respectively. EPS is expected to grow by 18.1% per annum. Return on equity is forecast to be 21.7% in 3 years.
Key information
17.9%
Earnings growth rate
18.1%
EPS growth rate
| Medical Equipment earnings growth | 17.1% |
| Revenue growth rate | 10.3% |
| Future return on equity | 21.7% |
| Analyst coverage | Good |
| Last updated | 24 Apr 2024 |
Recent future growth updates
Recent updates
Is Fisher & Paykel Healthcare (NZSE:FPH) Using Too Much Debt?
Mar 27
Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
Feb 22Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Business Is Yet to Catch Up With Its Share Price
Feb 05Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares Could Be 31% Above Their Intrinsic Value Estimate
Jan 03We Think Fisher & Paykel Healthcare (NZSE:FPH) Can Stay On Top Of Its Debt
Nov 30Fisher & Paykel Healthcare (NZSE:FPH) Could Be Struggling To Allocate Capital
Nov 12Estimating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Aug 28Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
Aug 10Here's Why Fisher & Paykel Healthcare (NZSE:FPH) Can Manage Its Debt Responsibly
Jul 02Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
May 01Returns On Capital Signal Tricky Times Ahead For Fisher & Paykel Healthcare (NZSE:FPH)
Jan 23Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?
Dec 27Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Oct 28Shareholders Are Optimistic That Fisher & Paykel Healthcare (NZSE:FPH) Will Multiply In Value
Oct 13Fisher & Paykel Healthcare (NZSE:FPH) Has A Pretty Healthy Balance Sheet
Sep 28Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Jul 24A Look Into Fisher & Paykel Healthcare's (NZSE:FPH) Impressive Returns On Capital
Jul 10Fisher & Paykel Healthcare (NZSE:FPH) Seems To Use Debt Quite Sensibly
Jun 12A Look At The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Apr 17Fisher & Paykel Healthcare (NZSE:FPH) Could Become A Multi-Bagger
Apr 04Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?
Mar 06With EPS Growth And More, Fisher & Paykel Healthcare (NZSE:FPH) Is Interesting
Jan 22Why The 41% Return On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Should Have Your Attention
Dec 26Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Dec 05This Is The Reason Why We Think Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Deserves A Bump Up To Their Compensation
Aug 11Is Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Worth NZ$31.6 Based On Its Intrinsic Value?
Aug 01Do Fisher & Paykel Healthcare's (NZSE:FPH) Earnings Warrant Your Attention?
Jul 07Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Jun 24A Look Into Fisher & Paykel Healthcare's (NZSE:FPH) Impressive Returns On Capital
May 01Here's Why We Think Fisher & Paykel Healthcare (NZSE:FPH) Is Well Worth Watching
Mar 28Is Fisher & Paykel Healthcare (NZSE:FPH) Using Too Much Debt?
Mar 16Have Insiders Been Selling Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares?
Mar 04How Much Is Fisher & Paykel Healthcare's (NZSE:FPH) CEO Getting Paid?
Feb 20Is Weakness In Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Feb 05Are Investors Overlooking Returns On Capital At Fisher & Paykel Healthcare (NZSE:FPH)?
Jan 25Did You Participate In Any Of Fisher & Paykel Healthcare's (NZSE:FPH) Incredible 325% Return?
Jan 14Here's What Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Shareholder Ownership Structure Looks Like
Jan 03Should You Be Adding Fisher & Paykel Healthcare (NZSE:FPH) To Your Watchlist Today?
Dec 24Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2027 | 2,478 | 507 | 359 | 608 | 4 |
| 3/31/2026 | 2,166 | 402 | 245 | 520 | 15 |
| 3/31/2025 | 1,942 | 332 | 175 | 452 | 16 |
| 3/31/2024 | 1,733 | 256 | 50 | 388 | 15 |
| 9/30/2023 | 1,694 | 262 | 31 | 393 | N/A |
| 6/30/2023 | 1,638 | 256 | 29 | 316 | N/A |
| 3/31/2023 | 1,581 | 250 | 27 | 238 | N/A |
| 12/31/2022 | 1,527 | 251 | 6 | 218 | N/A |
| 9/30/2022 | 1,472 | 251 | -15 | 199 | N/A |
| 6/30/2022 | 1,577 | 314 | 70 | 262 | N/A |
| 3/31/2022 | 1,682 | 377 | 155 | 324 | N/A |
| 12/31/2021 | 1,821 | 449 | 259 | 430 | N/A |
| 9/30/2021 | 1,961 | 521 | 363 | 535 | N/A |
| 6/30/2021 | 1,966 | 522 | 402 | 580 | N/A |
| 3/31/2021 | 1,971 | 524 | 441 | 625 | N/A |
| 12/31/2020 | 1,787 | 458 | 344 | 526 | N/A |
| 9/30/2020 | 1,603 | 392 | 247 | 426 | N/A |
| 6/30/2020 | 1,433 | 339 | 199 | 374 | N/A |
| 3/31/2020 | 1,264 | 287 | 151 | 321 | N/A |
| 12/31/2019 | 1,197 | 260 | 133 | 297 | N/A |
| 9/30/2019 | 1,130 | 233 | 115 | 273 | N/A |
| 6/30/2019 | 1,100 | 221 | 117 | 263 | N/A |
| 3/31/2019 | 1,070 | 209 | 120 | 253 | N/A |
| 12/31/2018 | 1,052 | 208 | 135 | 256 | N/A |
| 9/30/2018 | 1,034 | 206 | 151 | 259 | N/A |
| 6/30/2018 | 1,007 | 198 | 150 | 253 | N/A |
| 3/31/2018 | 981 | 190 | 149 | 248 | N/A |
| 12/31/2017 | 954 | 181 | 132 | 224 | N/A |
| 9/30/2017 | 928 | 172 | 116 | 200 | N/A |
| 6/30/2017 | 911 | 171 | N/A | 197 | N/A |
| 3/31/2017 | 894 | 169 | N/A | 194 | N/A |
| 12/31/2016 | 877 | 164 | N/A | 190 | N/A |
| 9/30/2016 | 860 | 160 | N/A | 186 | N/A |
| 6/30/2016 | 838 | 152 | N/A | 165 | N/A |
| 3/31/2016 | 815 | 143 | N/A | 145 | N/A |
| 12/31/2015 | 776 | 135 | N/A | 135 | N/A |
| 9/30/2015 | 736 | 126 | N/A | 126 | N/A |
| 6/30/2015 | 704 | 120 | N/A | 136 | N/A |
| 3/31/2015 | 672 | 113 | N/A | 147 | N/A |
| 12/31/2014 | 655 | 107 | N/A | 134 | N/A |
| 9/30/2014 | 637 | 101 | N/A | 122 | N/A |
| 6/30/2014 | 630 | 99 | N/A | 111 | N/A |
| 3/31/2014 | 623 | 97 | N/A | 100 | N/A |
| 12/31/2013 | 608 | 93 | N/A | 94 | N/A |
| 9/30/2013 | 593 | 88 | N/A | 88 | N/A |
| 6/30/2013 | 575 | 83 | N/A | 87 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: FPH's forecast earnings growth (17.9% per year) is above the savings rate (2.7%).
Earnings vs Market: FPH's earnings (17.9% per year) are forecast to grow faster than the NZ market (17.2% per year).
High Growth Earnings: FPH's earnings are forecast to grow, but not significantly.
Revenue vs Market: FPH's revenue (10.3% per year) is forecast to grow faster than the NZ market (5.6% per year).
High Growth Revenue: FPH's revenue (10.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: FPH's Return on Equity is forecast to be high in 3 years time (21.7%)